Navigation Links
Walkaway automation for nucleic acid purification

GenoVision AS, an innovative biotechnology company offering complete walkaway automation for the isolation and purification of nucleic acids, is now part of the QIAGEN Group of Companies and is now known as QIAGEN AS. QIAGEN AS focuses on low- to medium-throughput purification of DNA and
RNA from a variety of blood and tissue samples using MagAttract magnetic-bead technology in combination with BioRobot M-Series workstations.

QIAGEN AS is a leader in the nucleic acid diagnostics and HLA-testing market, and has developed two BioRobot workstations for easy and reliable purification of nucleic acids. High-quality nucleic acids can be isolated from a variety of sample sources, including dried blood, leukocytes, serum, buccal cells, cultured cells, biopsies, paraffinembedded tissue sections, animal tissue, and yeast cells. The BioRobot M-Series workstations increase productivity by improving the reproducibility, speed, and quality of nucleic acid purification, providing a complete system with flexible sample throughput for walkaway automation.

QIAGEN AS offers two BioRobot M-Series workstations the BioRobot M48 and BioRobot M96. Each workstation has a secure closure for safe processing of samples, in order to shield the user and reduce noise. Internal modules and precision liquid handling ensure cross-contaminationfree purification of nucleic acids using proven MagAttract magnetic-bead technology. The BioRobot M48 provides flexible sample throughput with processing of up to 48 samples in increments of 6 samples per run. The BioRobot M96 allows processing of up to 96 samples in increments of 8 samples per run. Highly pure nucleic acid, suitable for sensitive downstream applications, c
'"/>

Source:


Page: All 1 2

Related biology technology :

1. Laser microdissection and nucleic acid purification - a Leica - QIAGEN cooperation
2. Fully automated DNA purification and efficient multiplex PCR for analysis of microsatellite loci
3. DirectPrep 96 Miniprep System for cost-effective, high-throughput plasmid DNA purification
4. Ni-NTA Superflow Columns - automated large-scale purification of 6xHis-tagged proteins
5. New gravity-flow column gives faster and simpler purification of histidine-tagged proteins
6. DNA purification from pig ears to bird blood using proven DNeasy Technology

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Walkaway automation for nucleic acid purification

(Date:11/20/2009)...TLER TOLEDO recently announced that a free webinar...sing At-Line Particle Characterization”, wil...ar, the application of in situ particle characteri... optimize a series of roller compaction runs while...paction forces. , (PRWEB)...
(Date:11/19/2009)... be able to charge their cell phones and other per...ent discovery made by UC San Diego engineers could...t could do just this. , In recent research, pub...daru, a professor in the UCSD Department of Mechan...e student Mark Hoefer, have found that artificiall...
(Date:11/19/2009)...PRNewswire-FirstCall/ -- Omeros Corporation (Nasda...ults for the third quarter ended September 30, 200...Omeros reported a net loss of $3.9 million, or $1....llion, or $2.54 per share, for the same period in ..., the Company reported a net loss of $15.5 million...
(Date:11/19/2009)...DA, Md., Nov. 19 Spherix...otechnology for diabetes therapy, and a provider o...food, supplement, biotechnology and pharmaceutical...ly reported $6.3 million registered direct placeme...of its common stock and warrants to purchase up to...
Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2Nanotube defects equal better energy and storage systems 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
... metabolite concentrations of NKTR-102 significant...n possible with irinotecan, GENEVA and SAN CARLOS...KTR ) today reported positive Phase 1 data for its...-102 (PEG-irinotecan). The,data were presented at ...gets and Cancer Therapeutics in Geneva, Switzerlan...
...TON, N.J., Oct. 24 Orchid Cellmark Inc.,(Nasdaq: ...DNA testing,services, will release its third quart... 2008 at approximately 7:00 a.m. EDT, and is hosti...sults at 10:00 a.m. EDT on the,same day. Managemen...rter,2008 as well as operating highlights. A quest...
...EGO, Oct. 24 Favrille, Inc. (OTC,Bulletin Board: ...on-binding term sheet for a reverse merger whereby...f a private company, MyMedicalRecords.com, Inc.,("...lt in MMR becoming a,wholly-owned subsidiary of Fa... on the terms set forth in the non-binding term sh...
Other Biology Technology:Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EORTC-NCI-AACR Symposium 2Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EORTC-NCI-AACR Symposium 3Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EORTC-NCI-AACR Symposium 4Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EORTC-NCI-AACR Symposium 5Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EORTC-NCI-AACR Symposium 6Orchid Cellmark to Announce Third Quarter 2008 Financial Results on October 30, 2008 2Favrille Announces Execution of Non-binding Term Sheet for a Merger Transaction 2
(Date:11/23/2009)...usiness, posing dangers to human health and the en...ching a new project with funding from the U.S. Env...e fat and grease that contribute to millions of ov...ew tools to further reduce the risk of sewage spil...er systems, as opposed to "combined" systems that ...
(Date:11/22/2009)...d prenatally to tobacco smoke and during childhood...ccording to research done at Cincinnati Children,s...that up to 35 percent of ADHD cases in children be...minating both of these environmental exposures. Th... "Tobacco and lead exposure each have their own i...
(Date:11/22/2009)...etion can increase the likelihood of immune compli...international team of researchers reports in the N...s . When the gene, called UGT2B17, is missing from..., transplants have a significantly greater risk of...disease, in which immune cells from the donor atta...
Breaking Biology News(10 mins):Lose the fat: Targeting grease to curtail sewer overflows 2Exposure to lead, tobacco smoke raises risk of ADHD 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 476 Children Dead From Swine Flu 3A CDC 59232 176 Children Dead From Swine Flu 3A CDC 59232 276 Children Dead From Swine Flu 3A CDC 59232 3Vitamin D Good for Breast Cancer Patients 59227 1Vitamin D Good for Breast Cancer Patients 59227 2U S Bishops 3A Current Health Care Bills Violate Essential Principles 3B Will Seek Changes or Have to Oppose 59222 1U S Bishops 3A Current Health Care Bills Violate Essential Principles 3B Will Seek Changes or Have to Oppose 59222 2
..., the causative agent of anthrax, has been cleared...nistration (FDA). The test, known as the Gamma Pha...rmy Medical Research Institute of Infectious Disea...ability when used with clinical specimens. The ori...loped by the Centers for Disease Control and Preve...
... at Cornell University has received a grant to hel...aize (corn). , The project not only will allow re... function of single genes, one at a time, but also... gene. The seeds will be made widely available to ...ead to plants with tailor-made properties, such as...
...ing that the ability to taste bitter compounds has...Animals rely on chemical perception, including the... the harmful compounds found in nature. It is wide...y have reduced the importance of such chemical per...mans. , In new work, researchers including Nicole...
Other Biology News:'Mad cow' proteins successfully detected in blood 2'Mad cow' proteins successfully detected in blood 3Researcher gets NSF grant to create mutant maize lines 2Researcher gets NSF grant to create mutant maize lines 3
...ast Whole Genome ChIP-on-chip Microarray is specif... cerevisiae) DNA binding proteins by pairing chrom...icroarrays. This set delivers robust hybridization...ng events and fewer false positives. In addition, ...
... pombe Whole Genome ChIP-on-chip Microarray is spe...(S. pombe) DNA binding proteins by pairing chromat...roarrays. This set delivers robust hybridization a... events and fewer false positives. In addition, Ag...
...it is designed for easy transformation of the budd...or successful transformation simply by mixing a pl... cells. No complicated steps, such as centrifugati...cularly well suited for high-throughput transforma...
...effort to help promote genomics-based research wit...ylococcus aureus ORFmer set that contains PCR prim...he COL strain1. In addition, primer pairs are incl...u50 and N315 strains of S. aureus. The ORFmer set ...
Biology Products: